LABORATORIO FARMAC.ERFO (RK7) — Financial Flexibility Index
LABORATORIO FARMAC.ERFO (RK7) has a Financial Flexibility Index of 1.21x as of December 2023. Free cash flow of €2.74 Million (operating CF €1.30 Million minus capex €1.45 Million) represents 1% of total liabilities (€2.26 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LABORATORIO FARMAC.ERFO Financial Flexibility Index (2021–2023)
Historical Financial Flexibility Index trend for LABORATORIO FARMAC.ERFO across 3 annual periods. See working capital to net assets of LABORATORIO FARMAC.ERFO to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year free cash flow to debt coverage for LABORATORIO FARMAC.ERFO. For the full company profile including market capitalisation, see LABORATORIO FARMAC.ERFO (RK7) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.21x | €2.74 Million | €1.30 Million | €2.26 Million | ▲ +557.6% |
| 2022 | 0.18x | €1.94 Million | €761.80K | €10.53 Million | ▼ -83.9% |
| 2021 | 1.14x | €2.52 Million | €2.27 Million | €2.21 Million | — |